Novo Holding appeared to be the Corporate Investor, which was created in 1999. The venture was found in Europe in Sweden. The main office of represented Corporate Investor is situated in the Lund.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Harmony Biosciences, Spruce Biosciences.
The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Vivo Capital, Valor Equity Partners. In the next rounds fund is usually obtained by CRG L.P..
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017. Deals in the range of more than 100 millions dollars are the general things for fund.
Related Funds
Fund Name | Location |
Baltisches Haus | - |
Brooks Brothers | New York, New York, United States |
China Pacific Insurance | China, Shanghai |
Delta Capital Management | Nashville, Tennessee, United States |
Dr. Max Iann Invest | - |
GaiaX | Makati, Manila, Philippines |
IAG Firemark Ventures | Australia, New South Wales, Surry Hills |
John Bendheim Enterprises | - |
Junfa Group | China, Kunming, Yunnan |
KSVFinland | - |
Last Call Capital | - |
Mando Coperation | - |
Marathon Venture Partners | China, Shanghai |
Mitsubishi Corporation Fashion | Japan, Tokyo |
NEM Ventures | - |
NEXT Frontier Capital | Bozeman, Montana, United States |
Reliance Venture Asset Management | India, Maharashtra, Mumbai |
Schurz Communications | Indiana, Mishawaka, United States |
Shoe Investments | - |
Xinjiang Buttonwood Equity Investment | China, Ürümqi, Xinjiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Spruce Biosciences | $88M | 20 Feb 2020 | San Francisco, California, United States | ||
Spruce Biosciences | $20M | 02 Jan 2016 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Spruce Biosciences | $88M | 20 Feb 2020 | San Francisco, California, United States | ||
Spruce Biosciences | $20M | 02 Jan 2016 | San Francisco, California, United States |